Kalman Wijaya

Statistics

Publications

Citations

128

H-Index

Active since

2017

Affiliations

Syreon Research Institute (Hungary)(Current)

Eötvös Loránd University

Abbott (Switzerland)

National Public Health Organization

University of Utah

Kalman Wijaya is an author at Syreon Research Institute (Hungary) specializing in pharmaceutical assessment, multi-criteria decision making, and decision analysis.

Publications per year

2017–2018

Publications

Guidance toward the implementation of multicriteria decision analysis framework in developing countries

András Inotai, Huong Thanh Nguyen, Budi Hidayat et al. · Expert Review of Pharmacoeconomics & Outcomes Research · 2018 · 37 citations

Business, Decision Sciences, Health Policy +13

Development of multi-criteria decision analysis (MCDA) framework for off-patent pharmaceuticals – an application on improving tender decision making in Indonesia

András Inotai, Diana Brixner, Nikos Maniadakis et al. · BMC Health Services Research · 2018 · 35 citations · Full text

Business, Decision Sciences, Pharmaceutical Policy +16

Applying Multi-Criteria Decision Analysis (MCDA) Simple Scoring as an Evidence-based HTA Methodology for Evaluating Off-Patent Pharmaceuticals (OPPs) in Emerging Markets

Diana Brixner, Nikos Maniadakis, Zoltán Kaló et al. · Value in Health Regional Issues · 2017 · 32 citations · Full text

Business, Decision Sciences, Pharmaceutical Policy +8

An Evidence Framework for Off-Patent Pharmaceutical Review for Health Technology Assessment in Emerging Markets

Diana Brixner, Zoltán Kaló, Nikos Maniadakis et al. · Value in Health Regional Issues · 2018 · 24 citations · Full text

Pharmacy, Intellectual Property Law, Pharmaceutical Policy +17

1–4 of 4